Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
18M
-
Shares change
-
+1.43M
-
Total reported value, excl. options
-
$345M
-
Value change
-
+$34.8M
-
Number of buys
-
53
-
Number of sells
-
-23
-
Price
-
$19.20
Significant Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q2 2016
89 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock as of Q2 2016.
Evolent Health, Inc. - Class A Common Stock (EVH) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18M shares
of 112M outstanding shares and own 16.08% of the company stock.
Largest 10 shareholders include TPG Group Holdings (SBS) Advisors, Inc. (2.38M shares), FMR LLC (1.87M shares), JPMORGAN CHASE & CO (1.34M shares), Pennant Capital Management, LLC (1.34M shares), TimesSquare Capital Management, LLC (1.1M shares), WELLS FARGO & COMPANY/MN (1.07M shares), VANGUARD GROUP INC (1.02M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (917K shares), PERCEPTIVE ADVISORS LLC (873K shares), and GOLDMAN SACHS GROUP INC (540K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.